Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI 1823911 |
Trade Name | |
Synonyms | BI-1823911|BI1823911 |
Drug Descriptions |
BI 1823911 is a small molecule that selectively inhibits KRAS G12C, which may lead to inhibition of tumor cell proliferation and antitumor activity (Cancer Res 2021;81(13_Suppl):Abstract nr 1271). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | NA |
NCIT ID | C181997 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI 1701963 + BI 1823911 | BI 1701963 BI 1823911 | 0 | 1 |
BI 1823911 | BI 1823911 | 0 | 0 |
BI 1823911 + Midazolam | BI 1823911 Midazolam | 0 | 1 |